Overall rank by patents
#3,359
Across all tracked assignees
USPTO PatentsView assignee record - 111 granted patents across 7 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04W (WIRELESS COMMUNICATION NETWORKS).
The verdict
SCA holds 111 US patents across 7 technology areas, rank #3,359 of 50,000 tracked assignees.
SCA IPLA Holdings Inc. has been granted 111 US utility patents between 2015 and 2025, placing SCA IPLA Holdings Inc. at rank #3,359 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.1 claims per patent with primary concentration in H04W (WIRELESS COMMUNICATION NETWORKS). As a US Corporation, SCA IPLA Holdings Inc. is one of the more focused assignees in the PatentsView dataset. By volume, SCA sits between PTC Therapeutics, Inc. (111 patents, rank #3,355) and Vignet Incorporated (111 patents, rank #3,363) - the closest US assignees by grant volume. The composite Innovation Score of 40.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 21 grants, compared with 90 in the 2015–2019 window, a -77% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SCA IPLA Holdings Inc.'s 22.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SCA IPLA Holdings Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
PTC THERAPEUTICS, INC.
111 patents
ROM Technologies, Inc.
111 patents
S.V.V. TECHNOLOGY INNOVATIONS, INC.
111 patents
SAGEMCOM ENERGY & TELECOM SAS
111 patents
Seco Tools AB
111 patents
UNIVERSITE DE RENNES
111 patents
University of Science and Technology Beijing
111 patents
VigNet Incorporated
111 patents
SCA IPLA HOLDINGS INC.
111 patents
What this shows SCA holds 111 patents at rank #3,359, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #3,359 in granted patent volume.
Other assignees with the most granted patents in SCA's primary technology class.
SCA's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 5.4% |
| 2016 | 32 | 28.8% |
| 2017 | 22 | 19.8% |
| 2018 | 14 | 12.6% |
| 2019 | 16 | 14.4% |
| 2020 | 6 | 5.4% |
| 2021 | 4 | 3.6% |
| 2022 | 4 | 3.6% |
| 2023 | 2 | 1.8% |
| 2024 | 2 | 1.8% |
| 2025 | 3 | 2.7% |
Top 7 of 7 technology areas
Overall rank by patents
#3,359
Across all tracked assignees
40.9 out of 100
How to use this portfolio
SCA's 111 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.